Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The Role of Pharmacogenomics in Bipolar Disorder: Moving Towards Precision Medicine
Claudia Pisanu, Urs Heilbronner, Alessio Squassina
Molecular Diagnosis & Therapy (2018) Vol. 22, Iss. 4, pp. 409-420
Closed Access | Times Cited: 41

Showing 1-25 of 41 citing articles:

The role of pharmacogenomics in adverse drug reactions
Ramón Cacabelos, Natalia Cacabelos, Juan C. Carril
Expert Review of Clinical Pharmacology (2019) Vol. 12, Iss. 5, pp. 407-442
Closed Access | Times Cited: 98
Biomarkers for bipolar disorder: current status and challenges ahead
Antônio Lúcio Teixeira, Gabriela Delevati Colpo, Gabriel R. Fries, et al.
Expert Review of Neurotherapeutics (2018) Vol. 19, Iss. 1, pp. 67-81
Closed Access | Times Cited: 89
New Advances in the Pharmacology and Toxicology of Lithium: A Neurobiologically Oriented Overview
Analı́a Bortolozzi, Giovanna Fico, Michael Berk, et al.
Pharmacological Reviews (2024) Vol. 76, Iss. 3, pp. 323-357
Open Access | Times Cited: 9
Activating SIRT-1 Signalling with the Mitochondrial-CoQ10 Activator Solanesol Improves Neurobehavioral and Neurochemical Defects in Ouabain-Induced Experimental Model of Bipolar Disorder
Bidisha Rajkhowa, Sidharth Mehan, Pranshul Sethi, et al.
Pharmaceuticals (2022) Vol. 15, Iss. 8, pp. 959-959
Open Access | Times Cited: 24
Pharmacogenetics of Carbamazepine and Valproate: Focus on Polymorphisms of Drug Metabolizing Enzymes and Transporters
Teresa Iannaccone, Carmine Sellitto, Valentina Manzo, et al.
Pharmaceuticals (2021) Vol. 14, Iss. 3, pp. 204-204
Open Access | Times Cited: 30
Lithium response in bipolar disorder: Genetics, genomics, and beyond
Sergi Papiol, Thomas G. Schulze, Urs Heilbronner
Neuroscience Letters (2022) Vol. 785, pp. 136786-136786
Closed Access | Times Cited: 22
Perspectives on Precision Psychiatry Using Antipsychotics in the Management of Bipolar Disorder
Michele Fornaro, Alessandro Miola, Domenico De Berardis, et al.
Brain Sciences (2025) Vol. 15, Iss. 5, pp. 430-430
Open Access
Whole Genome Expression Analyses of miRNAs and mRNAs Suggest the Involvement of miR-320a and miR-155-3p and their Targeted Genes in Lithium Response in Bipolar Disorder
Claudia Pisanu, Eleni Merkouri Papadima, Carla Melis, et al.
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 23, pp. 6040-6040
Open Access | Times Cited: 35
Can an Integrated Science Approach to Precision Medicine Research Improve Lithium Treatment in Bipolar Disorders?
Jan Scott, Bruno Étain, Frank Bellivier
Frontiers in Psychiatry (2018) Vol. 9
Open Access | Times Cited: 30
Chronic Lithium Treatment Affects Anxious Behaviors and theExpression of Serotonergic Genes in Midbrain Raphe Nuclei of Defeated Male Mice
Dmitry A. Smagin, И. Л. Коваленко, Anna G. Galyamina, et al.
Biomedicines (2021) Vol. 9, Iss. 10, pp. 1293-1293
Open Access | Times Cited: 21
Evidence that genes involved in hedgehog signaling are associated with both bipolar disorder and high BMI
Claudia Pisanu, Michael J. Williams, Diana M. Ciuculete, et al.
Translational Psychiatry (2019) Vol. 9, Iss. 1
Open Access | Times Cited: 25
RNA Biomarkers in Bipolar Disorder and Response to Mood Stabilizers
Claudia Pisanu, Alessio Squassina
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 12, pp. 10067-10067
Open Access | Times Cited: 6
Association between Copy Number Variation and Response to Social Skills Training in Autism Spectrum Disorder
Kristiina Tammimies, Danyang Li, Ielyzaveta Rabkina, et al.
Scientific Reports (2019) Vol. 9, Iss. 1
Open Access | Times Cited: 16
Effects of chronic lithium treatment on anxious behaviors and serotonergic genes expression in the midbrain raphe nuclei in defeated male mice
Dmitry A. Smagin, И. Л. Коваленко, Anna G. Galyamina, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 13
Enhanced Molecular Appreciation of Psychiatric Disorders Through High-Dimensionality Data Acquisition and Analytics
Jaana van Gastel, Jhana O. Hendrickx, Hanne Leysen, et al.
Methods in molecular biology (2019), pp. 671-723
Closed Access | Times Cited: 14
An individualized medication model of sodium valproate for patients with bipolar disorder based on machine learning and deep learning techniques
Ping Zheng, Ze Yu, Liqian Mo, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 8
Transcriptomics and miRNomics data integration in lymphoblastoid cells highlights the key role of immune-related functions in lithium treatment response in Bipolar disorder
Nadia Cattane, Cindie Courtin, Elisa Mombelli, et al.
BMC Psychiatry (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 8
Defining phenotypes of long-term lithium and valproate response, including combination therapy: a modified application of the Alda scale in patients with bipolar disorders
Jinyoung Lee, Ji Hyun Baek, Dongbin Lee, et al.
International Journal of Bipolar Disorders (2020) Vol. 8, Iss. 1
Open Access | Times Cited: 12
Effects of Sex Differences and Combined Use of Clozapine on Initial Dosage Optimization of Valproic Acid in Patients with Bipolar Disorder
Wei Shen, Ke Hu, Hao-Zhe Shi, et al.
Current Pharmaceutical Design (2024) Vol. 30, Iss. 29, pp. 2290-2302
Closed Access | Times Cited: 1
Clinical, genetic, and brain imaging predictors of risk for bipolar disorder in high-risk individuals
Luca Steardo, Mirko Manchia, Bernardo Carpiniello, et al.
Expert Review of Molecular Diagnostics (2020) Vol. 20, Iss. 3, pp. 327-333
Closed Access | Times Cited: 11
Potential pharmacogenomic targets in bipolar disorder: considerations for current testing and the development of decision support tools to individualize treatment selection
Alfredo B. Cuéllar‐Barboza, Susan L. McElroy, Marin Veldić, et al.
International Journal of Bipolar Disorders (2020) Vol. 8, Iss. 1
Open Access | Times Cited: 11
The effect of chronic lithium treatment on hippocampal progenitor cells: Transcriptomic analysis and systems pharmacology
Mina Jahandideh, Erfan Ebrahimi, Mohammad Hosein Farzaei, et al.
Brain and Behavior (2023) Vol. 13, Iss. 10
Open Access | Times Cited: 3
SCN11A mRNA levels in female bipolar disorder PBMCs as tentative biomarker for distinct patient sub‐phenotypes
Irena Voinsky, Michael J. McCarthy, Tatyana Shekhtman, et al.
Drug Development Research (2019) Vol. 80, Iss. 8, pp. 1128-1135
Closed Access | Times Cited: 5
Stress exposure and well-being: correlates of meeting criteria for bipolar disorder, borderline personality disorder, or both
Marta Elliott, James M. Ragsdale
Social Psychiatry and Psychiatric Epidemiology (2021) Vol. 57, Iss. 9, pp. 1885-1896
Closed Access | Times Cited: 5
Prefrontal cortical thickness and clinical characteristics of long-term treatment response to valproate in bipolar disorder
Alejandra Monserrat Rodríguez‐Ramírez, Valente Cedillo‐Ríos, Claudia Becerra‐Palars, et al.
Psychiatry Research Neuroimaging (2021) Vol. 317, pp. 111382-111382
Closed Access | Times Cited: 4
Page 1 - Next Page

Scroll to top